INTRODUCTION

Bacopa monnieri (L) penn.syni Herpestis monnieria (L) .B. & K. named in various
Indian lauguages as Brahmi, Jal Neem, Nir Brahmi, Sarasvati, sambarani chetty is small prostate herb belonging to t family scrophulariaceae. Grows wild I damp places and marsh lands in the major parts of plains of India (1) it is known to have anti tumour activity (2, 18) .
The plant has been prescribed for nervous disorders such s insanity, epilepsy, neurasthenia, nervous break down etc. The fresh juice of the plant boiled in ghee may be given as such (brahmi oil). It is also used as brain tonic (1) . Isolation of alkaloids brahmine, hespestine, mannitol and saponins by the earlier workers (3) (4) (5) (6) (7) (8) . Sedative effect on dogs and frogs, tranquillizing effect and learning tests on albino rats have been reported by earlier workers (9-11).
The present study evaluates the anti-cancer property of Bacopa monnieri (L) Penn.
Materials and Methods
Whole plants of Bacopa monnieri were collected from Kinathukkadavu, 20km. away from Coimbatore, Tamil Nadu and identified by Dr. Mohan, Botanical survey of India, Coimbatore with the help of herbarium sheets.
Daltons lymphoma ascites tumor celkls (DLA) was obtained from amala cancer research centre, amala nagar trichur, kerala.
All the chemicals used in the present stud of analytical reagent quality.
Preparation of the drug
The fresh samples of plant (whole plant) were collected, air dried and powdered. The dried powder of the plant was cold extracted with 50% ethanol for seven days with occasional stirring. The process was repeated twice. (12) . The pooled extracts were concentrated, evaporated to dryness under reduced pressure. The extract was resuspended in1% gum acacia and subjected to the various studies.
Determination of cytotoxicity
Short term in vitro cytotoxicity assay was conducted using DLA tumour cells. 100,200,400 µg of EEBM and 0.1ml of 1% gum acacia (control) were incubated at 37oC with one million cells in 1ml PBS (Phonsphate Buffer Saline) for three hours. (13, 17) after incubation, he percentage dead cell as determined using tryptan bluce exclusion method.
Tumour reduction experiment
Swiss albino mice weighing 17 to 25 gm supplied from our animal hous, J.S.S College of Pharmacy, Ooty, were housed in well ventilated cages and fed with normal mouse pellet feed (Lipton India) and water ad libitum were used for the study. DLA was propagated into the peritoneal cavity of the mice by injecting one million cells. Te cells ere aspirated form developed tumour and washed with PBS. The solid tumours developed in mice by injected one million cells subcutaneously on hind limbs. The animals were divided into three groups. Each group was further subdivided in to two groups (Group a & b) were treated with 100, 200 mg/kg body wt of EEM respectively. Group 1 animals were treated 24 hours after tumour transplantation once daily for 10 days.
Group 2 animals were treated once daily for 10 days prior to tumous transplantation Group 4 animals were served as control treated with gum acacia (1%). Haematological studies.
In order to detect the influence of the EEBM on the hematological status of DLA bearing mice a comparison was made amongst the above mentioned four groups of mice on the 14 th day after transplantation with normal mice. Blood was drawn from each mouse in the conventional way and white blood cells count (WBC), red blood cells count (RBC), differential count and hemoglobin (Hb) percentage were estimated. (15)
Results
Short term in vitro cytotoxicity assay
The EEBM prepared was checked for their cytotoxicity by in vitro short term incubation with tumour cells (table 1) there was a dose dependent cytotoxicity to DLA tumour cells in vitro. The cytotoxicity was found to be 150µg/ml in vitro to these cells. It was found that treatment with 400 µg/ml produced a 70% death of DLA cells.
Tumour Reduction experiment
The effect of EEBM on tumour reduction is son in ( 
Haematological Parameters
Haematological Parameters (table 3) , of tumour bearing mice on day 14 were found to be significantly altered from the normal group. The total WBC count was found to be increase. In a differential count of WBC, the percent of neutrophils increased wile the lymphocyte count decreased. At the same time interval, EEBM (200mg/kg/da/oral) treatment for 10 days after tumour transplantation could restore those altered parameters near to normal.
Discussion and Conclusion
The use of chemotherapeutical drugs in cancer therapy involves the risk of life threatening host toxicity. Therefore the research goes on to develop the drugs which selectively act on tumour cells. The plant Bacopa Monnieri belonging to the family scophulariaceae have high medicinal properties. The present study also revealed its potential cytotoxic and anti-tumour properties. The EEBM has shown significant cytotoxicity assay was found to have significant cytotoxicity towards transformed cell lines. In solid tumour reduction studies the treatment of EEBM exhibited significant tumour reducing property analysis of the haemotological parameters at 14 days after transplantation of EEBM treated groups were able to reverse the changes in the haematological parameters consequent to tumour transplantation. The possible mechanism of anti-tumour action of EEBM against DLA cells may be due to radiomimetic, nucleotoxic and cytotoxic effect and acts in a manner similar to that of a spindle poison and inhibits cell mitosis. (16, 17) . 
